Skip to main content

Remote Job Finders (RJF)

Building Pharma’s Farm System: Eli Lilly, Boehringer Ingelheim, More Invest in the Future

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and venture funds to uncover cutting-edge scientific trends, determine their future focus points and even carve out a niche in an emerging geographical hotspot.

July Layoffs Skyrocket 487% YOY With Merck Cuts

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 people lost their jobs, due largely to Merck cutting roughly 6,000 employees. Sarepta Therapeutics and Moderna also announced significant workforce reductions.

Trial Failure of Vertex’s Next-Gen Pain Drug Mars Strong Q2 Earnings

Vertex reported healthy revenue in its second quarter earnings report, though news of VX-993’s mid-stage trial results and lack of alignment with the FDA regarding an expanded label for Journavx tempered analyst reactions, sending the stock down 13%.
Scroll to top